Somite AI

Somite AI is a Boston-based biotechnology company pioneering the use of artificial intelligence to revolutionize cell therapy and regenerative medicine. The company is building foundation models for human cells, leveraging AI to generate and analyze biological data at unprecedented scale and cost efficiency. By integrating large-scale predictive models with deep expertise in developmental and stem cell biology, Somite aims to accelerate the discovery, optimization, and delivery of novel cell therapies. Their approach promises to make cell therapy development more precise, scalable, and accessible, with the potential to transform treatment for a range of diseases.

What sets Somite apart is its world-class founding team, which includes repeat AI entrepreneur Dr. Micha Breakstone, the leader of MIT’s Fundamental AI Group, and several Harvard Medical School professors and National Academy of Sciences/Medicine members. The company fosters a collaborative, ambitious environment where cutting-edge science meets bold innovation. Employees at Somite have the opportunity to work alongside leaders in AI and biology, contribute to groundbreaking advances in human repair, and help shape the future of medicine in a mission-driven, high-impact setting.